This compound is a potent thrombin enzyme inhibitor designed for use as an anticoagulant drug. It works by inhibiting thrombin, a key protein in the blood clotting process, thereby reducing the formation of blood clots in blood vessels. It has potential for treating or preventing clot-related diseases such as myocardial infarction, stroke, and deep vein thrombosis (DVT). The compound has a specific structure targeted at the active site of thrombin, providing high efficacy and potentially fewer side effects than some drugs in the same class. However, it is still in the research and development stage and not widely used in clinical practice. Its guanidinopentanoic acid moiety enhances binding affinity to thrombin, making it a scaffold in designing enzyme inhibitors.